Skip to main content

Table 4 Complications between AML and ALL

From: Alternative donor peripheral blood stem cell transplantation for the treatment of high-risk refractory and/or relapsed childhood acute leukemia: a randomized trial

GroupaGVHDGrade II-IVaGVHDcGVHDIPFDHemorrhagic cystitisEBV infectionCMV infection
AML (n, %)23 (39)6 (10.2)12 (20.3)17 (28.8)15 (25.4)9 (15.3)22 (37.3)
ALL (n, %)21 (40.4)8 (15.4)13 (25)18 (34.6)18 (34.6)18 (34.6)26 (50)
P10.5680.6510.5450.3070.0260.186
  1. GVHD graft-versus-host disease, IPFD invasive pulmonary fungal disease, EBV Epstein–Barr virus, CMV cytomegalovirus